• Primary Histiocytic Sarcoma Presenting as a Breast Mass: A Case Report

• Bang Seong-Sik

• Kim Ye-Seul, Chung Min-Sung, Park Jeong-Seon, Choi Yun-Young, Shin Su-Jin

• Journal of Breast Cancer   2019  Volume.22  No.3 491 ~ 496

• Human Epidermal Growth Factor Receptor 2-Subtype Invasive Ductal Carcinoma Recurring as Basal-Human ...

• An Jeong-Shin

• Yoo Young-Eun, Kim Hyun-Goo, Woo Joo-Hyun, Lee Kyoung-Eun, Kwon Hyung-Ju, Lim Woo-Sung, Su...

• Journal of Breast Cancer   2019  Volume.22  No.3 484 ~ 490

• Early Rehabilitation after Total Mastectomy and Immediate Reconstruction with Tissue Expander Insert...

• Kim Kyou-Hyun

• Yeo Seung-Mi, Cheong In-Yae, Kim Yoon, Jeon Byung-Joon, Hwang Ji-Hye

• Journal of Breast Cancer   2019  Volume.22  No.3 472 ~ 483

• Gastric Complications after Adjuvant Radiotherapy for Breast Cancer

• Cho Won-Kyung

• Choi Doo-Ho, Park Won, Kim Hae-Young, Kim Seon-Woo, Cha Hye-Jung

• Journal of Breast Cancer   2019  Volume.22  No.3 464 ~ 471

• Measuring Tumor Extent Based on Subtypes Using Magnetic Resonance Imaging: Radiologic-Pathologic Dis...

• Bae Soong-June

• Ahn Sung-Gwe, Yoon Chang-Ik, Yang Ban-Seok, Lee Hak-Woo, Son Eun-Ju, Jeong Joon

• Journal of Breast Cancer   2019  Volume.22  No.3 453 ~ 463

• Changes in Biomarker Status in Metastatic Breast Cancer and Their Prognostic Value

• Woo Ji-Won

• Chung Yul-Ri, Ahn Soo-Min, Kang Eun-Young, Kim Eun-Kyu, Kim Se-Hyun, Kim Jee-Hyun, Kim In-...

• Journal of Breast Cancer   2019  Volume.22  No.3 439 ~ 452

• The Role of Neutrophil-lymphocyte Ratio and Platelet-lymphocyte Ratio in Predicting Neoadjuvant Chem...

• Kim Hee-Yeon

• Kim Tae-Hyun, Yoon Hye-Kyoung, Lee An-Bok

• Journal of Breast Cancer   2019  Volume.22  No.3 425 ~ 438

• Potential Benefits of Neoadjuvant Chemotherapy in Clinically Node-Positive Luminal Subtype? Breast C...

• Kim Hyung-Suk

• Yoo Tae-Kyung, Park Woo-Chan, Chae Byung-Joo

• Journal of Breast Cancer   2019  Volume.22  No.3 412 ~ 424

• Weight Gain during Neoadjuvant Chemotherapy is Associated with Worse Outcome among the Patients with...

• Fang Qiong

• Huang Jiahui, Gan Lu, Shen Kunwei, Chen Xiaosong, Wu Beiwen

• Journal of Breast Cancer   2019  Volume.22  No.3 399 ~ 411

• Prediction of Late Breast Cancer-Specific Mortality in Recurrence-Free Breast Cancer Survivors Treat...

• Baek Soo-Yeon

• Kwon Ji-Yeong, Lee Young-Joo, Gwark Sung-Chan, Lee Sae-Byul, Kim Ji-Sun, Chung Il-Yong, Ko...

• Journal of Breast Cancer   2019  Volume.22  No.3 387 ~ 398

• In Vitro and In Vivo Study on the Effect of Lysosome-associated Protein Transmembrane 4 Beta on the ...

• Tao Deyou

• Liang Junqing, Pan Yihong, Zhou Yanting, Feng Ying, Zhang Lin, Xu Jingjing, Wang Hui, ...

• Journal of Breast Cancer   2019  Volume.22  No.3 375 ~ 386

• Anticancer Activity of Tubulosine through Suppression of Interleukin-6-Induced Janus Kinase 2/Signal...

• Kim Byung-Hak

• Yi Eun-Hee, Li Yu-Chen, Park In-Chul, Park Jung-Youl, Ye Sang-Kyu

• Journal of Breast Cancer   2019  Volume.22  No.3 362 ~ 374

• Druggable Molecular Targets for the Treatment of Triple Negative Breast Cancer

• Nakhjavani Maryam

• Hardingham Jennifer E., Palethorpe Helen M., Price Tim J., Townsend Amanda R.

• Journal of Breast Cancer   2019  Volume.22  No.3 341 ~ 361